Background -Serotonin (5-HT) is present in the epithelial enterochromaffin cells (EC), mast cells of the lamina propria and enteric neurons. The 5-HT is involved in regulating motility, secretion, gut sensation, immune system and inflammation. Objective -Evaluate the effects of diabetes and quercetin supplementation on serotoninergic cells and its cell loss by apoptosis in jejunal mucosa of streptozotocin-induced diabetic rats (STZ-rats). Methods -Twenty-four male Wistar rats were divided into four groups: normoglycemic (C), normoglycemic supplemented with 40 mg/day quercetin (Q), diabetic (D) and diabetic supplemented with 40 mg/day quercetin (DQ). After 120 days, the jejunum was collected and fixated in Zamboni's solution for 18 h. After obtaining cryosections, immunohistochemistry was performed to label 5-HT and caspase-3. Quantification of 5-HT and caspase-3 immunoreactive (IR) cells in the lamina propria, villi and crypts were performed. Results -The diabetic condition displayed an increase of the number of 5-HT-IR cells in villi and crypts, while decreased number of these cells was observed in lamina propria in the jejunum of STZ-rats. In the diabetic animals, an increased density of apoptotic cells in epithelial villi and crypts of the jejunum was observed, whereas a decreased number of caspase-3-IR cells was observed in lamina propria. Possibly, quercetin supplementation slightly suppressed the apoptosis phenomena in the epithelial villi and crypts of the STZ-rats, however the opposite effect was observed on the 5-HT-IR cells of the lamina propria. Quercetin supplementation on healthy animals promoted few changes of serotoninergic function and apoptotic stimuli. Conclusion -These results suggest that quercetin supplementation mostly improved the serotonergic function affected by diabetes maybe due to antioxidant and anti-inflammatory properties of quercetin.
INTRODUCTION
The serotonin or 5-hydroxytryptamine (5-HT) is a major signaling molecule in the gastrointestinal tract (GIT) and is also considered as neurotransmitter, neuromodulator and a paracrine factor (1) (2) (3) (4) . The 5-HT is produced by the enterochromaffin (EC) cells, which form part of the epithelial lining of the gut. This signaling molecule is also present in the enteric neurons of the submucosal and myenteric plexuses of the Enteric Nervous System (ENS). The 5-HT release from EC cells, which is produced in response to the increase of the intraluminal pressure in the gastrointestinal, may stimulate both intrinsic and extrinsic primary afferent (sensory) neurons, via at least three different 5-HT receptors (e.g. 5-HT3, 5-HT4 and 5-HT1) (2, 5) . Activation of the 5-HT receptors may depolarize afferent nerve terminals, which can lead to a variety of physiological functions, including the initiation of peristalsis, vasodilatation, secretory reflexes and extrinsic primary afferents involved in transmission of sensory information to the Central Nervous System (2, (6) (7) (8) (9) .
Abnormal levels of 5-HT in the circulating blood plasma and intestinal tissues have been associated with diarrhea, dysmotility and inflammation. Furthermore, 5-HT displays a crucial pathophysiological role in some gastrointestinal disorders (10) (11) (12) .
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Juliana Vanessa Colombo MARTINS-PERLES, Isabela ZIGNANI, Sara Raquel Garcia de SOUZA, Flávia Cristina Vieira FREZ, Gleison Daion Piovezana BOSSOLANI and Jacqueline Nelisis ZANONI Diabetes mellitus (DM) is considered a complex and systemic metabolic disease characterized by the presence of hyperglycemia and increased oxidative stress (13, 14) . The diabetic neuropathy affects the organization of the ENS, resulting in quantitative loss of its cellular components with functional and morphological changes associated with the mechanisms of cellular plasticity (13, 15, 16) . Changes in the serotonin levels and serotonin-immunoreactive (-IR) cellular density has been already reported in GIT of diabetic animals (1, 8) . Additionally, changes in either levels of neuronal and mucosal serotonin or its receptors may be involved in the pathogenesis of diabetic diarrhea and the efficacy of the 5-HT3 receptor antagonists, such as ondansetron (17) and ramosetron (18) used in the treatment of diabetic diarrhea has been already reported.
In this context, quercetin, a common dietary flavonoid, gave rise to a promising antidiarrheal molecule. Several studies in the past have revealed that quercetin may produce antidiarrheal effects (19, 20) , mainly due to their antihistamine and anti-inflammatory activities (21, 22) . Furthermore, quercetin displays other important biological effects, including antioxidant, anticancer, hepatoprotective, antidiabetic and antibacterial actions (23) (24) (25) . In an electrophysiological study on mice, quercetin inhibits the 5-HT3 receptor-mediated ion current by interacting with pre-transmembrane domain I of Ca +2 channel (26) . For these reasons, studies suggest that quercetin may inhibit diabetic diarrhea by serotonergic mechanisms. Besides its antioxidant activity, quercetin may protect cells from oxidative stress-mediated apoptosis (27, 28) . In addition, quercetin acts on diverse signaling pathways, which mainly result in the suppression of the activation of inflammatory cells, decrease of oxidative stress due to its free radical scavenging, diminution of the activation of inflammatory cascades mediated by TNF-α and production of pro-inflammatory cytokines, thereby reducing the intestinal inflammation (24) .
In line with previous studies regarding the quercetin properties, the aim of the present study was to investigate the effect of diabetes and supplementation with quercetin on the serotonin-IR and caspase-3-IR cells in jejunal mucosa of diabetic rats in order to evaluate whether the diabetes impairs the serotoninergic intestinal function and whether quercetin avoids these diabetic consequences on the jejunum.
METHODS

Animals
Experiments were performed using twenty-four male Wistar rats (Rattus norvegicus) aged three months. The rats were obtained from the Central Biotery of the Universidade Estadual de Maringá and distributed into four groups: normoglycemic (C), normoglycemic supplemented with quercetin (Q), diabetic (D) and diabetic supplemented with quercetin (DQ) (Protocol number: 03/2009).
Animals were housed in individual cages for 120 days using a 12 h/12h light-dark cycle and controlled temperature (24±2ºC). The animals received balanced standard Nuvital chow (Nuvilab, Colombo, PR, Brazil). Food and water were available ad libitum. All animal procedures were conducted in accordance with the ethical principles of the Brazilian Society of Science in Laboratory Animals (SBCAL) and approved by the Committee of Ethics in Animal Experimentation (protocol number: 053/2009) of the Universidade Estadual de Maringá.
Animal model of diabetes
After a 14 h fast, diabetes mellitus was induced in the rats of the D and DQ groups by the injection of streptozotocin (35 mg/ kg, iv; Sigma, St. Louis, MO, USA) dissolved in citrate buffer, pH 4.5 (10 mM). After four days of diabetes induction, glycemia was determined using an Accu-Chek Active glucometer (Roche Diagnostics GmbH, Mannheim, Germany). The rats were considered diabetic whether the glucose levels were higher than 200 mg/dL, confirming the establishment of the experimental model.
The Q and DQ groups daily received water supplemented with quercetin (40 mg/day; Cromofarma, São Paulo, SP, Brazil) dissolved in alkalized water solution with NaOH (1N) 8% and dose was calculated as described by De Souza et al. (2017) (29) . The C and D groups only received water without quercetin supplementation.
After 120 days, the animals were weighed and anesthetized with 40 mg/kg Thiopental (i.p.; Cristália Laboratories, Itapira, SP, BRA). Blood samples were collected by cardiac puncture to determine glycemic levels using the glucose oxidase method (30) . The jejunum was collected.
Tissue preparation
The jejunum was fixed in Zamboni's solution (4% paraformaldehyde and 0.4% picric acid in phosphate buffer) for 18 h. After fixation, the tissue was repeatedly washed in phosphate buffered saline (PBS; pH 7.4, 0.1 M) for 12 h. Afterwards, cryoprotection was performed in a solution of 18% sucrose in PBS for 24 h. After sample immersion in the soaking medium for frozen tissue (OCT 4583 compound; Tissue-Tek), tissues were frozen in liquid nitrogen and stored in a freezer at -70°C.
Afterwards, 10-µm semi-serial sections were obtained and disposed in identified slides previously prepared using poly-Llysine (Sigma-Aldrich, St. Louis, MO, USA) solution in water concentration of 1:10 and stored at -20°C. Slides with five slices were prepared per animal to perform the immunohistochemistry.
Immunohistochemistry
Frozen histological sections were washed in PBS containing 0.5% Triton X-100 (2x10 min) (Sigma-Aldrich, Inc., São Paulo, Brazil), followed by incubation in PBS containing 10% goat serum for 1 h. After incubation, the intestinal samples were incubated in a solution containing the following primary antibodies: rabbit anti-5-HT (1:300, (Sigma-Aldrich, Co., St Louis, MO, USA) and goat anti-caspase-3 (1:200; Santa Cruz Biotechnology, inc., CA, USA) for 48 h at 4°C in a moist chamber. After incubation in the primary antibodies, the jejunal tissues were washed in PBS containing 0.5% Triton X-100 (3x10 min). After that, the intestinal samples were rinsed in PBS containing 0.5% Triton X-100 (2x10 min) and then, the jejunal segments were incubated in a solution that contained corresponding secondary antibodies: Alexa Fluor 488-conjugated donkey anti-rabbit IgG (Molecular Probes, Eugene, Oregon, USA) and Alexa Fluor 546-conjugated donkey anti-goat IgG (Molecular Probes, Eugene, Oregon, USA) for 2 h at room temperature. The histological sections were mounted using a ProLong Gold antifade reagent (Molecular Probes, Eugene, Oregon, USA).
Image analysis
The images of the histological sections were obtained using high resolution camera Moticam ® 2500 5.0 Mega Pixel (Motic China Group Co., Shanghai, China) coupled to a fluorescence microscope Olympus ® BX40 (Olympus Co., Japan) and transferred to a PC using the software Motic images Plus ® 2.0 mL (Motic China Group Co., Shanghai, China). The images were captured using a 10x objective lens coupled with an eyepiece lens 10x, thereby the total magnification was 100x times. To obtain only the figures of this paper and morphological description of 5-HT-IR cells in lamina propria, the images were acquired using a Zeiss LSM 5 Pascal laser-scanning microscope (Carl Zeiss).
The numbers of caspase-3-IR and 5-HT-IR cells were separately quantified in the zone of villi, crypts and lamina propria, as well as their merge of these biological markers in each region. A total of either 50 units of villi or crypts or lamina propria (in the same zone of villi-crypts) per animal was evaluated.
Statistical analysis
The data were submitted to the analysis of normality and homoscedasticity and data comparison was obtained by Randomized Block design. Data were tested for normality by the D'Agostino-Pearson test; comparisons between groups were performed by Newman-Keuls test for parametric data and nonparametric data was performed by Fisher's test for nonparametric data. Statistical analyses were performed using Statistic ® 7.1 software and Graph-Pad Prism ® 6.1 software. For comparison between the different groups, values of P<0.05 were considered significant and data were reported as average ± standard error.
RESULTS
At the end of the experimental period, D and DQ groups showed a significant (P<0.00) increase in glycemia, was accompanied by significant body weight loss. Glycemic values were 149.1±25.32 (C group), 144.7±16.33 (Q group) 564.4 mg/dL ±45.33 (D group) and 542.4 mg/dL ± 46.18 (DQ group) and final weight of groups C=521.1 g ±15.07, Q=500.0 g ±12.46, D=331.0 g ±16. 39 and DQ=321.7 g ±20. 25 .
FIGURES 1 and 2 illustrate the histological sections used to quantify 5-HT-IR-cells, caspase-3-IR-cells and 5-HT-IR-caspase-3-IR cells. In the FIGURE 2, the villi can be visualized, especially for 5-HT-IR enteroendocrine cells (white arrow) in a higher magnification. In the lamina propria, next to the crypts, typical cells with morphological features similar to the mastocytes can be visualized in 5-HT-IR/caspase-3-IR cells (indicated by red arrows).
5-HT-IR cells, caspase-3-IR cells and their merge (5-HT-IRcaspase/3-IR cells) in the villus and crypts
In the villus, there was an increase in the number of the 5-HT-IR cells in the Q group (P<0.02) and D group (P<0.009) (vs C, FIGURE 3A ). The supplementation with quercetin in the DQ group promoted a reduction of 42.70% in the number of these cells (vs D, P<0.006). The values observed in the DQ group were similar to the C group (P>0.05, FIGURE 3A ). In the crypt, there was an increase in the number of 5HT-IR cells in Q, D and DQ groups (vs C, P<0.0001, FIGURE 3B ), and this increase was more significant in the group DQ.
In villus and crypt, no differences were detected in the number of caspase-3-IR cells of Q group (vs C, FIGURE 3C and 3D). In these two regions in diabetic animals (D group), there was an increase in the number of caspase-3-IR cells (vs C, P<0.001, FIGURE 3C and D). Quercetin administration (DQ group) only reduced the number of caspase-3-IR cells in the crypt (vs D, P>0.05, FIGURE 3D ).
The numbers of 5-HT-IR/Caspase-3-IR cells in the villus for Q groups (P<0.02) and D (P<0.01) were higher than the control (FIGURE 3E). In the crypt, there also was a significant increase in 5-HT-IR/Caspase-3-IR cells in D group (vs C, FIGURE 3F). In DQ group, there was a significant reduction in the number of 5-HT-IR/Caspase-3-IR cells in the villus (vs D, P<0.008, FIGURE  3E ) and crypt (vs D, P>0.05, FIGURE 3F ).
5-HT-IR cells, caspase-3-IR cells and their merge (5-HT-IR/ caspase-3-IR cells) in the lamina propria
The number of 5-HT-IR cells in the lamina propria was reduced in the Q (P<0.001), D (P<0.005) and DQ (P<0.0002) (vs C, FIGURE 4A) groups. However, regarding Caspase-3-IR and 5-HT-IR-Caspase-3-IR cells, there was no significant change between the studied groups (P>0.05, FIGURE 4B and 2C) .
DISCUSSION
The diabetic condition was confirmed during the experiment through polyuria, polydipsia and polyphagia observed (data not shown). The severe hyperglycemia was comproved (group D and DQ >500 mg/dL).
The initial weight of the animals in the different groups showed no statistically significant difference (data not shown), while the weight at the end of the experimental protocol was significantly reduced in the diabetic groups. The lower weight gain in diabetic rats is characteristic and has been evidenced in other experiments performed in our research group (31, 32) .
Serotonin is produced by the epithelial EC cells, mast cells, T cells of lamina propria and enteric neurons (3) . In this study, the immunohistochemical technique was used to label 5-HT-IR cells and caspase-3-IR cells in three different areas of GIT: epithelial villi, crypts and lamina propria.
The remarkably increased number of 5-HT-IR cells in the villus and crypt in the diabetic rats suggests an increase in the serotonin content in this region of epithelium. Recent studies strongly suggest that 5-HT can act as a pro-inflammatory signaling molecule in the mucosal layer of the small intestine (2, 3, 10, 33) . The increase in the 5-HT availability can activate primary afferent nerves, thereby contributing to intensify the motility and/or secretion during diabetes, which may be one of the causes of diabetic diarrhea (34) . Furthermore, increased plasma levels of 5-HT are considered a biomarker for diabetic complications (35) .
Regarding 5-HT-IR-caspase/3-IR cells, the diabetic condition yielded an increased number of these cells in the villi and crypt. Caspase-3 is an effector caspase that leads to the apoptotic morphological changes, such as: membrane blebbing, cytoplasmic and nuclear condensation, DNA fragmentation and formation of apoptotic bodies (36) . In addition, hyperglycemia induces an increase of apoptosis phenomena associated to the increased oxidative stress (37) . In the quantitative analysis, the diabetes promoted an increase of the number of caspase-3-IR cells in the villus (93.9%) and crypt (84%). These results demonstrated that the cell death was occurring in different cell types and not only in 5-HT-IR cells.
The quercetin supplementation in the DQ group promoted a significant reduction in the number of 5-HT-IR cells in the villi and enhance of these cells, even being non-significant, in the crypts in relation to the D group. These results were opposite to those observed in D group in relation to the C group, which indicate a serotoninergic reduction in the villi, though a proliferative action of 5-HT-IR cells was observed in the crypts. Anti-and proliferative effects of quercetin on different cell types have been described in other studies (38) (39) (40) . As above described, the significant reduction of 5-HT-IR cells by quercetin may indicate a beneficial anti-inflammatory effect since serotonin is considered a pro-inflammatory molecule.
In the villus and crypts, a lower number of 5-HT apoptotic cells was observed in diabetic animals that consumed quercetin compared to diabetic animals without supplementation, which demonstrates that the quercetin displayed a protective effect on this cell population. Such results may be indirectly explained since quercetin is an antioxidant, which displays free radical-scavenging activities (24, 29) , thereby the reduction of hyperglycemia-induced oxidative stress may result in a decrease of intracellular apoptotic stimuli (41) . Furthermore, quercetin has anti-apoptotic actions already described (24) (25) (26) (27) (28) (29) .
In the analysis of caspase-3-IR cells in the villi and crypt, no alterations were observed in the DQ group in relation to the D group. Based on these results, quercetin yielded a protective effect especially in the 5-HT-IR cells on diabetic rats. As previously described, immunohistochemical staining for caspase-3 demonstrated that diabetes remarkably induced mucosal apoptosis in crypt epithelial cells. The integrity of the mucosal epithelium of GIT depends upon the balance among cell proliferation, cell migration and cellular death via apoptosis (42) . In addition, quercetin exerts protective effects on cellular components of ENS (e.g. enteric glial cells and enteric neurons) and interstitial cells of Cajal by prevention of cellular loss (29, 32, 33, 43) and from the results obtained in this work, regarding 5-HT-IR epithelial cells, quercetin supplementation was able to slightly prevent cell apoptosis induced by diabetes.
The quercetin-supplemented healthy rats displayed an increase of 5-HT-IR epithelial cells (villi and crypts) and reduction of these cells in lamina propria. Additionally, increased apoptosis of 5-HT cells was detected in the jejunum villi of rats of the Q group. It is known that secretion of 5-HT by the enterochromaffin cell may stimulate peristaltic reflexes and, thus this would modify intestinal motility. Furthermore, the enteroendocrine cell-derived 5-HT is an essential component of the gastrointestinal inflammatory response and is also a hormone, which inhibits osteoblast proliferation and promotes hepatic regeneration (8) . For these reasons, quercetininduced serotonergic effects should be further investigated.
In the lamina propria, the 5-HT-IR cells displayed a granular appearance and an circular or elliptical in form, when examined under confocal microscopy. No other 5-HT-IR morphological features were seen in these layers. Stoyanova and Gulubova (44) also detected 5-HT positive cells in the lamina propria of the colon in humans using toluidine blue and tryptase staining, indicating they are mast cells. Other researchers reported that rodent mast cells may synthesize and release 5-HT to the appropriate target cells (2) . In the lamina propria, mast cells are preferentially located next to nerve terminals, where they are activated by secreted neuropeptides, such as substance P. When these cells are stimulated by substance P, mast cells release inflammatory mediators, such as serotonin and proteases as well as proinflammatory cytokines (45) .
The results observed in the lamina propria 5-HT-IR cells demonstrated a statistically significant reduction in the number of these cells in the Q, D and DQ groups. Mast cells are involved in mediating subsequent tissue repair and exacerbating and/or modulating inflammation (46) . Quercetin is known as a natural inhibitor of mast cell activation through the inhibition of Ca 2+ influx, thereby demonstrating that quercetin may have acted as a natural anti-inflammatory since mast cells release many cytokines involved in inflammatory process (47) . Therefore, the quercetin stabilizes the cell membrane of mast cells and basophils that contains histamine and serotonin, preventing the release of these chemicals mediators (47, 48) , thereby downregulating the density of 5-HT-IR mast cells observed in this work.
The decreased number of 5-HT-IR cells in the lamina propria of diabetic rats was not caused by increase of apoptosis process of these cells. Furthermore, there was no significant alteration in the number of 5-HT-IR/caspase-3-IR cells in lamina propria of the analyzed groups, including the D group. The quercetin supplementation reverted the reduction of 5-HT-IR cells in D group, although the quercetin has also well-known stabilizing capacity of cell membrane of mast cells, which are important regulators of intestinal function and tight junction integrity (49) . However, quercetin may have normalized the cell death process in other cell types in the lamina propria, which was altered due to diabetic condition. Based on quercetin supplementation effects under healthy condition, slight changes, in which most results were non-significant, were observed in the serotoninergic function and apoptotic stimuli. For these reasons, regarding our results in CQ group, non-toxic effects were observed but further studies have to be performed using different quercetin doses and supplementation times.
CONCLUSION
Therefore, diabetes promoted increased number of cells 5-HT-IR in villus and crypt, although decreased density of these cells in the lamina propria was observed in the jejunum of diabetic animals. On the other hand, diabetic rats that consumed quercetin presented a lower number of 5-HT-IR cells with values similar to the control. Furthermore, the apoptosis process was increased in the villi and crypt regions in the jejunum of the diabetic group. The quercetin supplementation possibly suppressed the apoptosis of the 5-HT-IR cells in the jejunal mucosa of the diabetic rats, but other studies should be done to better investigate the effects of quercetin on the apoptotic events. For these reasons, in general, supplementation with quercetin revealed to display mainly protective actions against serotoninergic changes in the jejunal mucosa of diabetic rats probably due to its antioxidant and anti-inflammatory properties.
